Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (291-300 of 663) with videos related to

Pageof 67
Sort By:
Journal of Immunological Methods|December 9, 2003
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cellsAnnika C Karlsson, Jeffrey N Martin, Sophie R Younger, et al.
Retrovirology|August 25, 2016
New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapyVanessa Sue Wacleche, Jean-Philippe Goulet, Annie Gosselin, et al.
AIDS (London, England)|December 11, 2013
A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cellsSteven A Yukl, Elizabeth Sinclair, Ma Somsouk, et al.
AIDS (London, England)|July 11, 2009
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expressionJennifer E Snyder-Cappione, Christopher P Loo, Karina I Carvalho, et al.
Journal of Virology|August 20, 2010
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responsesApril L Ferre, Peter W Hunt, Delandy H McConnell, et al.
The Journal of Infectious Diseases|October 16, 2021
Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral TherapyJared Stern, Ajantha Solomon, Ashanti Dantanarayana, et al.
AIDS (London, England)|August 14, 2013
Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllersAlice K Asher, Glenn-Milo Santos, Jennifer Evans, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The Immunophenotype and Proviral Landscape of HIV-infected CD4 T Cells During Antiretroviral TherapyCyrille L Delley, Sakshi Shah, Kevin M Joslin, et al.
Clinical Pharmacology and Therapeutics|August 24, 2018
Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb TrialSulggi A Lee, Julian H Elliott, James McMahon, et al.
The Journal of Infectious Diseases|April 12, 2012
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected womenChristina M Parrinello, Elizabeth Sinclair, Alan L Landay, et al.
Pageof 67

Showing results (291-300 of 663) with videos related to

Sort By:
Pageof 67
Journal of Immunological Methods|December 9, 2003
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cellsAnnika C Karlsson, Jeffrey N Martin, Sophie R Younger, et al.
Retrovirology|August 25, 2016
New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapyVanessa Sue Wacleche, Jean-Philippe Goulet, Annie Gosselin, et al.
AIDS (London, England)|December 11, 2013
A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cellsSteven A Yukl, Elizabeth Sinclair, Ma Somsouk, et al.
AIDS (London, England)|July 11, 2009
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expressionJennifer E Snyder-Cappione, Christopher P Loo, Karina I Carvalho, et al.
Journal of Virology|August 20, 2010
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responsesApril L Ferre, Peter W Hunt, Delandy H McConnell, et al.
The Journal of Infectious Diseases|October 16, 2021
Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral TherapyJared Stern, Ajantha Solomon, Ashanti Dantanarayana, et al.
AIDS (London, England)|August 14, 2013
Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllersAlice K Asher, Glenn-Milo Santos, Jennifer Evans, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The Immunophenotype and Proviral Landscape of HIV-infected CD4 T Cells During Antiretroviral TherapyCyrille L Delley, Sakshi Shah, Kevin M Joslin, et al.
Clinical Pharmacology and Therapeutics|August 24, 2018
Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb TrialSulggi A Lee, Julian H Elliott, James McMahon, et al.
The Journal of Infectious Diseases|April 12, 2012
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected womenChristina M Parrinello, Elizabeth Sinclair, Alan L Landay, et al.
Pageof 67